News releases

ALL

May 14, 2021 corporate

corporate

Notice Regarding Decision on the Candidates for Directors(66 KB)
May 14, 2021 product/service

product/service

Notice RegardingLaunch of1 Ingredient/ 2 Products of Generic Drugs for KYOSOMIRAI PHARMA(118 KB)
Apr 23, 2021 performance

performance

Notice Regarding Full-Year Earnings Forecasts for Fiscal Year Ended March 2021 and Recording of Extraordinary Loss(30 KB)
Apr 16, 2021 other

other

Notice Regarding Disclosure of “Names of Drug Product Manufacturers” for Products that KYOSOMIRAI PHARMA Holds Marketing Approvals(107 KB)
Apr 05, 2021 other

other

Notice Regarding Free Provision of Nafamostat Mesilate Products(106 KB)
Mar 26, 2021 M&A/partnership

M&A/partnership

Notice Regarding a Merger of Three Transport Business Companies and a Change of the Name to “KYOSO LOGISTICS CO., LTD.”(137 KB)
Mar 25, 2021 product/service

product/service

Notice Regarding Launch of 1 Ingredient / 2 Products of Generic Drugs for KYOSOMIRAI PHARMA(133 KB)
Mar 11, 2021 other

other

Notice of the Posting of a Gain on Sale of Investment Securities (Extraordinary Income)(64 KB)
Feb 15, 2021 product/service

product/service

Notice Regarding Marketing Approvals for 2 Ingredients / 5 Products of Generic Drugs for KYOSOMIRAI PHARMA(164 KB)
Feb 09, 2021 performance

performance

Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year Ending March 31, 2021(321 KB)
Jan 18, 2021 product/service

product/service

Announcement of Release of the Online Medical Examination / Dosing Guidance System named “KAITOS”(176 KB)
Jan 15, 2021 M&A/partnership

M&A/partnership

Announcement of Capital and Business Alliance with KUBIX Inc.(70 KB)
Dec 17, 2020 product/service

product/service

Announcement of an exclusive distribution agreement to supply COVID-19 detection kits(116 KB)
Dec 16, 2020 other

other

Regarding a Reduction of Directors’ Compensation and Compliance Enhancement Initiatives for Recurrence Prevention(148 KB)